Effectiveness of Pentoxifylline in the treatment of oral submucous fibrosis patients: a case-control study

Applied Cancer Research

Table 7 Distribution of difficulty in swallowing, difficulty in speech, cheek flexibility according to group in different time periods

		Group	N	Mean Rank	Sum of Ranks	U value	P value
DIFFICULTY IN SWALLOWING	Baseline	Pentoxyfylline	40	32.50	1040.00
		Placebo	40	32.50	1040.00	0.000	1.000
		Total	80
	1st Month	Pentoxyfylline	40	32.00	1024.00
		Placebo	40	33.00	1056.00	0.587	0.558
		Total	80
	2nd Month	Pentoxyfylline	40	32.00	1024.00
		Placebo	40	33.00	1056.00	0.587	0.558
		Total	80
	3rd Month	Pentoxyfylline	40	32.00	1024.00
		Placebo	40	33.00	1056.00	0.587	0.558
		Total	80
	Baseline	Pentoxyfylline	40	32.50	1040.00
		Placebo	40	32.50	1040.00	0.000	1.000
		Total	80
	1st Month	Pentoxyfylline	40	32.50	1040.00
DIFFICULTY IN SPEECH		Placebo	40	32.50	1040.00	0.000	1.000
		Total	80
	2nd Month	Pentoxyfylline	40	32.50	1040.00
		Placebo	40	32.50	1040.00	0.000	1.000
		Total	80
	3rd Month	Pentoxyfylline	40	32.50	1040.00
		Placebo	40	32.50	1040.00	0.000	1.000
		Total	80